These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18031247)

  • 61. Toll-like receptor agonists: a patent review (2011 - 2013).
    Hussein WM; Liu TY; Skwarczynski M; Toth I
    Expert Opin Ther Pat; 2014 Apr; 24(4):453-70. PubMed ID: 24456079
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Intra-Tumoral Activation of Endosomal TLR Pathways Reveals a Distinct Role for TLR3 Agonist Dependent Type-1 Interferons in Shaping the Tumor Immune Microenvironment.
    Thomas G; Micci L; Yang W; Katakowski J; Oderup C; Sundar P; Wang X; Geles KG; Potluri S; Salek-Ardakani S
    Front Oncol; 2021; 11():711673. PubMed ID: 34381732
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Toll-like receptors as therapeutic targets for cancer.
    Holldack J
    Drug Discov Today; 2014 Apr; 19(4):379-82. PubMed ID: 24012797
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antimicrobial Peptide Omiganan Enhances Interferon Responses to Endosomal Toll-Like Receptor Ligands in Human Peripheral Blood Mononuclear Cells.
    Grievink HW; Jirka SMG; Woutman TD; Schoonakker M; Rissmann R; Malone KE; Feiss G; Moerland M
    Clin Transl Sci; 2020 Sep; 13(5):891-895. PubMed ID: 32314872
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The functional and inflammatory response of brain endothelial cells to Toll-Like Receptor agonists.
    Johnson RH; Kho DT; O' Carroll SJ; Angel CE; Graham ES
    Sci Rep; 2018 Jul; 8(1):10102. PubMed ID: 29973684
    [TBL] [Abstract][Full Text] [Related]  

  • 66. PP040. Activation of endosomal toll-like receptors in first trimester trophoblasts.
    Stødle G; Tangerås LH; Olsen GD; Leknes AH; Gundersen AS; Skei B; Vikdal AJ; Ryan L; Steinkjer B; Myklebost MF; Langaas M; Austgulen R; Iversen AC
    Pregnancy Hypertens; 2013 Apr; 3(2):81. PubMed ID: 26105896
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Chemical reagents modulate nucleic acid-activated toll-like receptors.
    Li X; Sun X; Guo X; Li X; Peng S; Mu X
    Biomed Pharmacother; 2022 Mar; 147():112622. PubMed ID: 35008000
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Rapid translocation of intracellular toll-like receptors depends on endosomal NADPH oxidase.
    Müller-Calleja N; Hollerbach A; Canisius A; Orning C; Strand S; Lackner KJ
    Eur J Immunol; 2023 Sep; 53(9):e2250271. PubMed ID: 37366283
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical investigations of Toll-like receptor agonists.
    Meyer T; Stockfleth E
    Expert Opin Investig Drugs; 2008 Jul; 17(7):1051-65. PubMed ID: 18549341
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Endosomal Toll-Like Receptors as Therapeutic Targets for Autoimmune Diseases.
    Miyake K; Shibata T; Fukui R; Murakami Y; Sato R; Hiranuma R
    Adv Exp Med Biol; 2024; 1444():97-108. PubMed ID: 38467975
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The role of endosomal toll-like receptors in asthma.
    Papaioannou AI; Spathis A; Kostikas K; Karakitsos P; Papiris S; Rossios C
    Eur J Pharmacol; 2017 Aug; 808():14-20. PubMed ID: 27677226
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Chemical Strategies to Enhance the Therapeutic Efficacy of Toll-like Receptor Agonist Based Cancer Immunotherapy.
    Lee SN; Jin SM; Shin HS; Lim YT
    Acc Chem Res; 2020 Oct; 53(10):2081-2093. PubMed ID: 32966047
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Agonist and antagonist ligands of toll-like receptors 7 and 8: Ingenious tools for therapeutic purposes.
    Patinote C; Karroum NB; Moarbess G; Cirnat N; Kassab I; Bonnet PA; Deleuze-Masquéfa C
    Eur J Med Chem; 2020 May; 193():112238. PubMed ID: 32203790
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The Toll for Trafficking: Toll-Like Receptor 7 Delivery to the Endosome.
    Petes C; Odoardi N; Gee K
    Front Immunol; 2017; 8():1075. PubMed ID: 28928743
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Regulators of innate immunity as novel targets for panviral therapeutics.
    Es-Saad S; Tremblay N; Baril M; Lamarre D
    Curr Opin Virol; 2012 Oct; 2(5):622-8. PubMed ID: 23017246
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Endolysosomal compartments as platforms for orchestrating innate immune and metabolic sensors.
    Miyake K; Saitoh SI; Sato R; Shibata T; Fukui R; Murakami Y
    J Leukoc Biol; 2019 Oct; 106(4):853-862. PubMed ID: 31219657
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [TLR function in autoimmunological processes].
    Klonowska-Szymczyk A; Wolska A; Robak E
    Postepy Hig Med Dosw (Online); 2009 Jul; 63():331-9. PubMed ID: 19644149
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Therapeutic potential of toll-like receptors in treatment of gynecological cancers.
    Moradi-Marjaneh R; Hassanian SM; Hasanzadeh M; Rezayi M; Maftouh M; Mehramiz M; Ferns GA; Khazaei M; Avan A
    IUBMB Life; 2019 May; 71(5):549-564. PubMed ID: 30729633
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Determining Endosomal Toll-Like Receptors Gene Expression in NK Cells After Stimulation with Specific Agonists.
    Alicata C; Veneziani I; Ricci B; Moretta L; Maggi E
    Methods Mol Biol; 2023; 2700():151-162. PubMed ID: 37603179
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Mast cells in viral infections].
    Witczak P; Brzezińska-Błaszczyk E
    Postepy Hig Med Dosw (Online); 2012 Apr; 66():231-41. PubMed ID: 22706109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.